Study in Allergic Adults to Support the Development of Immunological Assays

NCT01320137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-06-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop and characterize immunological assays on blood samples.

Conditions

  • Immunologic Tests

Interventions

PROCEDURE

Blood withdrawal

Blood sampling

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-05-11
Completion
2011-05-11

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01320137 on ClinicalTrials.gov